We note that a New Ray Medicine International Holding Limited (HKG:6108) insider, Shenglei Qian, recently sold HK$154k worth of stock for HK$1.92 per share. However we note that the sale only shrunk their holding by 0.04%.

Check out our latest analysis for New Ray Medicine International Holding

New Ray Medicine International Holding Insider Transactions Over The Last Year

In fact, the recent sale by Shenglei Qian was the biggest sale of New Ray Medicine International Holding shares made by an insider individual in the last twelve months, according to our records. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (HK$0.98). So it may not tell us anything about how insiders feel about the current share price.

The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).

Does New Ray Medicine International Holding Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. New Ray Medicine International Holding insiders own 47% of the company, currently worth about HK$766m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Do The New Ray Medicine International Holding Insider Transactions Indicate?

An insider hasn't bought New Ray Medicine International Holding stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing New Ray Medicine International Holding. Case in point: We've spotted 1 warning sign for New Ray Medicine International Holding you should be aware of.

But note: New Ray Medicine International Holding may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.